Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://murraymsau786953.mdkblog.com/45047845/retaglutide-a-promising-glp-1-receptor-agonist